Filgotinib
GS-US-419-3896
Phase 3 small_molecule terminated
Quick answer
Filgotinib for Crohn's Disease is a Phase 3 program (small_molecule) at Lakefront Biotherapeutics NV with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Lakefront Biotherapeutics NV
- Indication
- Crohn's Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated